Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

19. Juli 2021 16:30 ET | Quelle: Atreca, Inc.

Atreca Announces Appointment of Dr. Stacey Ma and Stephen R. Brady to its Board of Directors

SAN CARLOS Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique...
14. Mai 2021 08:30 ET | Quelle: Atreca, Inc.

Atreca to Present at Upcoming Virtual Investor Conferences

SAN CARLOS, Calif., May 14, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique discovery...
13. Mai 2021 07:30 ET | Quelle: Atreca, Inc.

Atreca Reports First Quarter 2021 Financial Results and Recent Corporate Developments

SAN CARLOS Calif., May 13, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique...
06. April 2021 16:30 ET | Quelle: Atreca, Inc.

Atreca to Present at Upcoming Virtual Investor Conferences

REDWOOD CITY, Calif., April 06, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique discovery...
10. März 2021 16:30 ET | Quelle: Atreca, Inc.

Atreca Announces Poster Presentation at the Virtual American Association for Cancer Research (AACR) Annual Meeting

SOUTH SAN FRANCISCO, Calif., March 10, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated...
25. Februar 2021 16:05 ET | Quelle: Atreca, Inc.

Atreca Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Corporate Developments

SOUTH SAN FRANCISCO, Calif., Feb. 25, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through...
22. Februar 2021 16:30 ET | Quelle: Atreca, Inc.

Atreca to Participate at Upcoming Virtual Investor Conferences

SOUTH SAN FRANCISCO, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through...
12. November 2020 08:30 ET | Quelle: Atreca, Inc.

Atreca Reports Third Quarter 2020 Financial Results and Recent Corporate Developments

SOUTH SAN FRANCISCO, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through...
06. November 2020 08:30 ET | Quelle: Atreca, Inc.

Atreca to Present at Upcoming Virtual Investor Conferences

SOUTH SAN FRANCISCO, Calif., Nov. 06, 2020 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique...
14. Oktober 2020 16:30 ET | Quelle: Atreca, Inc.

Atreca Announces Poster Presentations at the 2020 Society for Immunotherapy of Cancer (SITC) Annual Meeting

SOUTH SAN FRANCISCO, Calif., Oct. 14, 2020 (GLOBE NEWSWIRE) -- Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through...

Vorherige Seite

Nächste Seite